ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes. (Q35192848)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes. |
scientific article |
Statements
ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes (English)
Anthony Cerami
Ann N Dunne
Paolo L Proto
Claes-Goran Ostenson
Rita I Kirk
Ioannis N Petropoulos
13 March 2015
1 January 2014
1 reference
1 reference
1 reference